0001144204-17-048290 Sample Contracts

MOLECULIN BIOTECH, INC. Common Stock (par value $0.001 per share) At Market Issuance Sales Agreement

Moleculin Biotech, Inc. • September 15th, 2017 • Pharmaceutical preparations • New York

• Company
  Moleculin Biotech, Inc.
• Filed
  September 15th, 2017
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

Moleculin Biotech, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”), with Roth Capital Partners, LLC (“ ROTH”), and National Securities Corporation (“National” and ROTH, individually an “Agent” and collectively, the “Agents”) as follows: